COVID-19 Prognostic Tool

Estimate mortality rates in patients with COVID-19. Adapted from CDC materials.

About

This tool is based on data from the CDC Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). Accessed on April 7, 2020.

The CDC references a report from the Chinese Center for Disease Control and Prevention, updated through February 11, 2020. In this report, a total of 44,672 case records were classified as confirmed cases of COVID-19 (through positive viral nucleic acid throat swab samples.)

The overall case-fatality rate was 2.3% (1023 deaths among 44,672 confirmed cases.) Age was a strong risk factor for severe illness, complications, and death with the case fatality rate being highest among older persons. In addition, the case-fatality rate was elevated among those with pre-existing comorbid conditions such as cardiovascular disease, diabetes, chronic respiratory disease, hypertension, and cancer.

The American data comes from a CDC Report titled Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020. In this report, a total of 4,226 COVID-19 cases in the United States that occurred during February 12–March 16, 2020 were analyzed by age group. Overall, 80% of deaths associated with COVID-19 were among adults aged ≥65 years with the highest percentage of severe outcomes among persons aged ≥85 years. In contrast, no ICU admissions or deaths were reported among persons aged ≤19 years. Similar to reports from other countries, this finding suggests that the risk for serious disease and death from COVID-19 is higher in older age groups.

References

Management of Patients with Confirmed 2019-NCoV.

Centers for Disease Control and Prevention, 6 Apr. 2020

The COVID-19 Prognostic Tool calculator is created by QxMD.
Default Units

1. Age?

0/9 completed

About

This tool is based on data from the CDC Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). Accessed on April 7, 2020.

The CDC references a report from the Chinese Center for Disease Control and Prevention, updated through February 11, 2020. In this report, a total of 44,672 case records were classified as confirmed cases of COVID-19 (through positive viral nucleic acid throat swab samples.)

The overall case-fatality rate was 2.3% (1023 deaths among 44,672 confirmed cases.) Age was a strong risk factor for severe illness, complications, and death with the case fatality rate being highest among older persons. In addition, the case-fatality rate was elevated among those with pre-existing comorbid conditions such as cardiovascular disease, diabetes, chronic respiratory disease, hypertension, and cancer.

The American data comes from a CDC Report titled Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020. In this report, a total of 4,226 COVID-19 cases in the United States that occurred during February 12–March 16, 2020 were analyzed by age group. Overall, 80% of deaths associated with COVID-19 were among adults aged ≥65 years with the highest percentage of severe outcomes among persons aged ≥85 years. In contrast, no ICU admissions or deaths were reported among persons aged ≤19 years. Similar to reports from other countries, this finding suggests that the risk for serious disease and death from COVID-19 is higher in older age groups.

References

Management of Patients with Confirmed 2019-NCoV.

Centers for Disease Control and Prevention, 6 Apr. 2020

The COVID-19 Prognostic Tool calculator is created by QxMD.
Contributed By:
  • Benjamin Mammon, MD Candidate
Legal Notices and Disclaimer

© 2020 QxMD Software Inc., all rights reserved. No part of this service may be reproduced in any way without express written consent of QxMD. This information should not be used for the diagnosis or treatment of any health problem or disease. This information is not intended to replace clinical judgment or guide individual patient care in any manner. Click here for full notice and disclaimer.